Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC(R) in Prostate Cancer
December 10, 2014 01:40 ET | Bavarian Nordic A/S
KVISTGAARD, Denmark, Dec. 10, 2014 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that it has reached the planned enrollment of 1,200 patients in the PROSPECT Phase 3...
Bavarian Nordic Reac
Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC® in Prostate Cancer
December 10, 2014 01:30 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGAARD, Denmark, December 10, 2014 - Bavarian...
Bavarian Nordic opnå
Bavarian Nordic opnår mål for rekruttering af patienter i det pivotale fase 3 forsøg med PROSTVAC® til behandling af prostatacancer
December 10, 2014 01:30 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGÅRD, Danmark - 10. december 2014 - Bavarian...
Bavarian Nordic Announces First Subject Dosed with MVA-BN(r) Filo in a Phase 1 Study Investigating a New Prime-Boost Regimen of Ebola Candidate Vaccines
December 04, 2014 01:38 ET | Bavarian Nordic A/S
First human trial investigating MVA-BN® Filo as an Ebola vaccine MVA-BN Filo is being investigated as a booster in an ongoing Phase study 1 of the cAd3-EBO Z vaccine being developed by...
Bavarian Nordic Anno
Bavarian Nordic Announces First Subject Dosed with MVA-BN® Filo in a Phase 1 Study Investigating a New Prime-Boost Regimen of Ebola Candidate Vaccines
December 04, 2014 01:30 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} First human trial investigating MVA-BN® Filo...
Bavarian Nordic offe
Bavarian Nordic offentliggør at første forsøgsperson er vaccineret med MVA-BN® Filo i et nyt fase 1 forsøg med en prime-boost forsøgsvaccine mod ebola
December 04, 2014 01:30 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Forsøget er det første i mennesker, hvor...
Total number of voti
Total number of voting rights and share capital in Bavarian Nordic A/S
November 30, 2014 06:00 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGAARD, Denmark, November 30, 2014 - Bavarian...
Indberetning af akti
Indberetning af aktiekapital og stemmerettigheder for Bavarian Nordic A/S
November 30, 2014 06:00 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGÅRD, Danmark - 30. november 2014 - Bavarian...
Bavarian Nordic A/S
Bavarian Nordic A/S - Vedtægter
November 26, 2014 05:54 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Opdaterede vedtægter for Bavarian Nordic A/S ...
Bavarian Nordic A/S
Bavarian Nordic A/S - Articles of Association
November 26, 2014 05:54 ET | Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Updated Articles of Association for Bavarian...